跳至主要内容
临床试验/NCT03401151
NCT03401151招募中不适用

Changes in Skeletal Muscle Over Time in Severe Heart Failure

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Metabolic signature of muscle, messenger RNA (mRNA) gene expression

研究概览

简要总结

The mechanisms behind heart failure are largely unknown. Despite an increasing arsenal of pharmacological therapies, cardiovascular disease is still the most common cause of death in the western world, which demonstrates a pronounced need for more patient-related mechanistic research. Cachexia and limited exercise capacity are the symptoms that best match prediction of heart failure, both of which are symptoms involving a dysfunctional skeletal muscle. An increased understanding of the mechanisms and signaling pathways connects the failure heart with skeletal muscle dysfunction is likely to lead both to discoveries of prognostic factors and possible therapeutic options.

The study is a prospective, non-blinded, study. The study will consist of the assignment of patients with heart failure, New York Heart Association (NYHA) III-IV, 60-80 years old. One hundred (100) patients will be enrolled in this study.

详细描述

The primary objective is to investigate how changes in the skeletal muscle coincide with changes in physical performance, cardiac function, and prognosis in patients with heart failure, and changes over time. Therefore, the investigators will investigate patients with severe heart failure at 'baseline' and on a second follow-up occasion after 12-16 months.

The secondary and tertiary objective is to investigate how changes in the metabolic signature of blood and satellite cells coincide with changes in physical performance, cardiac function, and prognosis in patients with heart failure, and changes over time. Patient recruitment is expected to occur over 36 months.

The study will be conducted in Sweden at Karolinska University Hospital, Huddinge.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
60 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Metabolic signature of muscle, messenger RNA (mRNA) gene expression

时间窗: Change from baseline metabolic signature at 24 months

Metabolomics profile using nuclear magnetic resonance (NMR)

Metabolic signature of muscle, messenger RNA (mRNA) gene

时间窗: Change from baseline metabolic signature at 24 months

Metabolomics profile using liquid chromatography-high-resolution mass spectrometry (LC-HRMS)

次要结局

  • Expression levels of targeted genes using transcriptomics(Change from baseline metabolic signature at 24 months)
  • Metabolic signature of blood, mRNA gene expression(Change from baseline metabolic signature at 24 months)
  • Metabolic signature of satellite cells, mRNA gene expression(Change from baseline metabolic signature at 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Gustafsson Assoc Prof

Professor

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验